Sharps Technology Inc. financial data

Symbol
STSS, STSSW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
105 Maxess Road, Ste. 124, Melville, NY
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 147 % -23%
Quick Ratio 53.3 % +202%
Debt-to-equity 40.8 %
Return On Equity -101 % -23.9%
Return On Assets -71.5 % -13.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.6M shares +145%
Common Stock, Shares, Outstanding 28.6M shares +145%
Entity Public Float 7.62M USD +22.8%
Common Stock, Value, Issued 2.86K USD +145%
Weighted Average Number of Shares Outstanding, Basic 21.6M shares +84.9%
Weighted Average Number of Shares Outstanding, Diluted 21.6M shares +84.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.43M USD -19.7%
General and Administrative Expense 7.62M USD -0.93%
Operating Income (Loss) -9.04M USD +4.46%
Nonoperating Income (Expense) -181K USD -147%
Net Income (Loss) Attributable to Parent -8.21M USD -3.06%
Earnings Per Share, Basic -0.93 USD/shares -272%
Earnings Per Share, Diluted -0.93 USD/shares -145%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.48M USD -49.3%
Inventory, Net 1.89M USD +90%
Assets, Current 3.53M USD -14.1%
Property, Plant and Equipment, Net 6.28M USD -11.4%
Intangible Assets, Net (Excluding Goodwill) 42.4K USD -30.5%
Other Assets, Noncurrent 118K USD -79.9%
Assets 9.93M USD -15.8%
Accounts Payable, Current 878K USD
Liabilities, Current 2.55M USD -12.4%
Deferred Income Tax Liabilities, Net 162K USD
Liabilities 2.72M USD -12.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 352K USD -37.1%
Retained Earnings (Accumulated Deficit) -28.2M USD -41%
Stockholders' Equity Attributable to Parent 7.22M USD -16.9%
Liabilities and Equity 9.93M USD -15.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.89M USD +8.4%
Net Cash Provided by (Used in) Financing Activities 3.24M USD +9865%
Net Cash Provided by (Used in) Investing Activities -2.85K USD +98.3%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 28.6M shares +145%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.85M USD -270%
Deferred Tax Assets, Valuation Allowance 6.47M USD +23.5%
Deferred Tax Assets, Gross 5.05M USD +71.9%
Depreciation 190K USD -10.4%
Payments to Acquire Property, Plant, and Equipment 163K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.42M USD -13.6%
Property, Plant and Equipment, Gross 8.07M USD -1.84%
Preferred Stock, Shares Issued 1 shares 0%
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 35.1M USD +24.7%
Preferred Stock, Shares Outstanding 1 shares 0%
Amortization of Intangible Assets 5.29K USD +32.9%
Share-based Payment Arrangement, Expense 202K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%